期刊文献+

辛伐他汀对老年高胆固醇血症患者骨密度和骨转换影响的研究 被引量:4

下载PDF
导出
摘要 目的观察他汀类药物辛伐他汀对合并骨量减少的老年高胆固醇血症患者骨密度和骨转换的影响。方法入选老年高胆固醇血症合并骨量减少患者55人,平均年龄(66.8±4.7)岁,男性31人,女性24人,随机分两组分别给予辛伐他汀(20mg/d)(治疗组,29人)和饮食控制(对照组,26人),两组患者每天补充钙剂1000mg,在治疗前后检查血脂和骨代谢指标,并进行骨密度测定。结果经过治疗6个月后,治疗组患者总胆固醇、低密度脂蛋白胆固醇、甘油三酯明显低于治疗前,骨代谢指标治疗组总碱性磷酸酶、骨钙素无明显变化,尿脱氧吡啶啉/肌酐比值明显降低,相应的对照组各项骨代谢指标治疗前后均无明显变化。治疗前后腰椎和股骨骨密度虽然有所增加,但差异不显著。结论辛伐他汀对老年高胆固醇合并骨量减少患者骨代谢的影响可能主要通过抗骨吸收作用,对骨合成代谢无明显影响。
出处 《中国老年学杂志》 CAS CSCD 北大核心 2009年第4期457-459,共3页 Chinese Journal of Gerontology
  • 相关文献

参考文献8

  • 1Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins [ J ]. Science, 1999 ;286 (5446) : 1946-9. 被引量:1
  • 2Rejnmark L, Olsen ML, Johnsen SP,et al. Hip fracture risk in statin users-a population-based Danish case-control study [ J ].Osteoporos Int,2004;15(6) :452-8. 被引量:1
  • 3Hatzigeorgiou C, Jackson JL Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis [ J ]. Osteoporos Int, 2005 ; ( 8 ) :990-8. 被引量:1
  • 4Majima T, Komatsu Y, Fukao A, et al. Short-term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia [ J]. Endocr J,2007 ;54( 1 ) : 145-51. 被引量:1
  • 5Bjamason NH, Riis B J, Christiansen C. The effect of fluvastatin on parameters of bone remodeling[ J ]. Osteoporos Int ,2001 ; 12 ( 5 ) :380-4. 被引量:1
  • 6Kajinami K, Takekoshi N, Matsui S,et al. Effect of pretreatment vitamin D levels on in vivo effects of atorvastatin on bone metabolism in patients with heterozygous familial hypercholesterolemia[ J ]. Am J Cardiol,2003; 92(9) :1113-6. 被引量:1
  • 7Rosenson RS, Tangney CC, Langman CB, et al. Short-term reduction in bone markers with high-dose simvastatin [ J ]. Osteoporos Int, 2005 ; 16 (10) : 1272-6. 被引量:1
  • 8刘铭,朱振安.他汀类药物防治骨质疏松症的基础及临床研究进展[J].中国骨质疏松杂志,2006,12(1):85-88. 被引量:2

二级参考文献32

  • 1于纪珠,刘晓民,林春艳,朱宏.辛伐他汀体外促进骨形成作用的初步研究[J].中国骨质疏松杂志,2004,10(2):230-231. 被引量:2
  • 2Bellosta S,Ferri N,Bemini F,et al.Non-lipid related effects of statins.Ann Med,2000,32:164-176. 被引量:1
  • 3Mundy G,Garrett R,Harris S,et al.Stimulation of bone formation in vitro and in rodents by statins.Science,1999,286:1946-1949. 被引量:1
  • 4Sugiyama M,Kodama T,Konishi K.et al.Compactin and simvastatin,but not pravastatin,induce bone morphogenetic protein-2 in human osteosarcoma cells.Biochem Biophys Res Co mmun,2000,271:688-692. 被引量:1
  • 5Maeda T,Matsunuma A,Kawane T,et al.Simvastatin promotes osteoblast differentiation and mineralizatong in MC3T3-E1 cells.Biochem Biophys Res Commun,2001,280:874-877. 被引量:1
  • 6Maeda T,Matsunuma A,Kurahashi I,et al.Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells.J Cell Biochem,2004,92:458-471. 被引量:1
  • 7Ohnaka K,Shimoda S,Nawata H,et al.Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts.Biochem Biophys Res Commun,2001,287:337-342. 被引量:1
  • 8Li X,Cui Q,Kao C,et al.Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARgamma2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures.Bone,2003,33:652-659. 被引量:1
  • 9Parhami F,Mody N,Gharavi N,et al.Role of the cholesterol biosynthetic pathway in osteoblastic differentiation of marrow stromal cells.J Bone Miner Res,2002,17:1997-2003. 被引量:1
  • 10Woo J,Knsai S,Stern P,et al.Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts.J Bone Miner Res,2000,15:650-658. 被引量:1

共引文献1

同被引文献47

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部